The Hospital Acquired Staphylococcus Aureus Bacteremia programme aims to prevent and control Staphylococcus aureus bloodstream infections in healthcare settings. 

This page includes resources and strategies for infection prevention, surveillance, and management to enhance patient safety.

Title Description Link to Document
Guide to the surveillance of healthcare-associated Staphylococcus aureus bacteraemia (HA-SAB)

This guide is for district health boards in New Zealand to use so that they can report on HA-SAB consistently, contributing to accurate national data and reliable information for quality improvement activities.

The guide supports existing surveillance using the case definition that the Hand Hygiene New Zealand programme has endorsed. This guide aims to support and standardise existing surveillance activities. It does not replace or inform clinical assessment of infections for patient management.  

 Guide to the surveillance  [PDF, 1.3 MB]
of healthcare-associated  [PDF, 1.3 MB]
Staphylococcus aureus [PDF, 1.3 MB]
bacteraemia (May 2025) [PDF, 1.3 MB]
Healthcare-associated infection Severity Assessment Code (SAC) examples 2022–23 

These documents contain examples of healthcare-associated infection Severity Assessment Code (SAC) ratings.

They should be used as guides only and all events should be rated on actual outcome for the consumer. 

Healthcare-associated infection Severity Assessment Code (SAC) examples 2022–23. [DOCX, 30 KB]

Healthcare-associated infection Severity Assessment Code (SAC) examples 2022–23 [DOCX, 69 KB]

Healthcare-associated infection Severity Assessment Code (SAC) examples 2022–23 [PDF, 114 KB]